Toggle navigation
Home
Search
Services
Blog
Contact
About
Testing in vivo of HIV-immunopathogenic hypotheses using new kinetic techniques
Hellerstein, Marc Kopel
University of California Berkeley, Berkeley, CA, United States
Search 163 grants from Marc Hellerstein
Search grants from University of California Berkeley
Share this grant:
:
:
Abstract
Funding
Institution
Related projects
Publications
Comments
Recent in Grantomics:
Massachusetts Institute of Technology
vs. funders. Who wins?
Read more...
How should you pick the next fundable research topic?
Read more...
Recently viewed grants:
Trial of Roflumilast in Asthma Management (TRIM)
Influenza and Other Emerging Infectious Diseases in Vietnam (U01)
Jumpstart Summer Enrichment Program
Core - Patient Research Resources
Advanced Nurse Education
Recently added grants:
Partnering with a State Food Bank to Provide Tobacco Treatment to Underserved Smokers
Optimizing Psychotherapy for Older Veterans with Chronic Pain
CMA: Immune/Inflammatory Priming in Exacerbating Responses to GWVI Stressors: Implications for GWVI Treatments
Preventing levodopa induced dyskinesia in Parkinsons Disease with Statins
Identifying molecular markers that predict relapse after therapy discontinuation inchronic myeloid leukemia.
Abstract
Funding Agency
Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Method to Extend Research in Time (MERIT) Award (R37)
Project #
5R37AI043866-14
Application #
8053822
Study Section
Special Emphasis Panel (NSS)
Program Officer
Bridges, Sandra H
Project Start
1998-01-01
Project End
2013-03-31
Budget Start
2011-04-01
Budget End
2012-03-31
Support Year
14
Fiscal Year
2011
Total Cost
$434,130
Indirect Cost
Institution
Name
University of California Berkeley
Department
Nutrition
Type
Schools of Earth Sciences/Natur
DUNS #
124726725
City
Berkeley
State
CA
Country
United States
Zip Code
94704
Related projects
Publications
Veerapathran, Anandharaman; Pidala, Joseph; Beato, Francisca et al.
(2013)
Human regulatory T cells against minor histocompatibility antigens: ex vivo expansion for prevention of graft-versus-host disease.
Blood 122:2251-61
Comments
Be the first to comment on Marc Hellerstein's grant